Cargando…
Plazomicin Is Active Against Metallo-β-Lactamase-Producing Enterobacteriaceae
Plazomicin is an aminoglycoside that was approved in June 2018 by the US Food and Drug Administration for the treatment of complicated urinary tract infections, including pyelonephritis, due to Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae, and Proteus mirabilis. Plazomicin was engin...
Autores principales: | Serio, Alisa W, Keepers, Tiffany, Krause, Kevin M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6446133/ https://www.ncbi.nlm.nih.gov/pubmed/30968059 http://dx.doi.org/10.1093/ofid/ofz123 |
Ejemplares similares
-
Evaluation of the Bactericidal Activity of Plazomicin and Comparators against Multidrug-Resistant Enterobacteriaceae
por: Thwaites, M., et al.
Publicado: (2018) -
1345. Comparative Activity of Plazomicin and Other Aminoglycosides Against Enterobacteriaceae Isolates From Various Infection Sources From Hospitalized Patients in the United States
por: Castanheira, Mariana, et al.
Publicado: (2018) -
New Delhi Metallo-β-Lactamase–producing Enterobacteriaceae, United States
por: Rasheed, J. Kamile, et al.
Publicado: (2013) -
Metallo-β-Lactamase (MBL)-Producing Enterobacteriaceae in United States Children
por: Logan, Latania K., et al.
Publicado: (2016) -
Activity of Plazomicin against Enterobacteriaceae Isolates Collected in the United States Including Isolates Carrying Aminoglycoside-Modifying Enzymes Detected by Whole Genome Sequencing
por: Castanheira, Mariana, et al.
Publicado: (2017)